Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare

Journal of Urology

Volumn 189, Issue 3, 2013, Pages 867-870

  Loeb, Stacy ^a   Carter, H Ballentine ^b   Berndt, Sonja I ^c   Ricker, Winnie ^d   Schaeffer, Edward M ^b  

^a NEW YORK UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

biopsy; hospitalization; infection; patient admission; prostate

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CYSTITIS; ENDOCARDITIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPOTENSION; ICD-9; INFECTION; KIDNEY INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATITIS; SEPSIS; URINARY TRACT INFECTION;

AGED; BIOPSY, NEEDLE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MEDICARE; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84873739031     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.10.005     Document Type: Article

References (11)

1. American Cancer Society Cancer Facts & Figures 2012 www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/ acspc-031941.pdf Accessed May 28, 2012
2. H.G. Welch, E.S. Fisher, D.J. Gottlieb Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era J Natl Cancer Inst 99 2007 1395
3. S. Loeb, H.B. Carter, S.I. Berndt Complications after prostate biopsy: data from SEER-Medicare J Urol 186 2011 1830
4. M.A. Liss, A. Chang, R. Santos Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy J Urol 185 2011 1283
5. P.S. Romano, L.L. Roos, J.G. Jollis Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives J Clin Epidemiol 46 1993 1075
6. G.G. Zhanel, T.L. Hisanaga, N.M. Laing Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) Int J Antimicrob Agents 26 2005 380
7. F.H. Schröder, J. Hugosson, M.J. Roobol Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 2012 981
8. R.K. Nam, R. Saskin, Y. Lee Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 183 2010 963
9. B. Djavan, M. Waldert, A. Zlotta Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study J Urol 166 2001 856
10. S.V. Carlsson, E. Holmberg, S.M. Moss No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer BJU Int 107 2011 1912
11. S. Loeb, S. van denHeuvel, X. Zhu Reply from Authors re: Alexandre R. Zlotta, Robert K. Nam. To Biopsy or Not to Biopsy - Thou Shall Think Twice Eur Urol 61 2012 e53